These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 33693450)

  • 1. Amplification and expression of c-MET correlate with poor prognosis of patients with gastric cancer and upregulate the expression of PDL1.
    Yang Y; Wang C; Dai C; Liu X; Li W; Huang M; Zhao X; Ji D; Li J; Guo W
    Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):547-557. PubMed ID: 33693450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
    Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
    Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MACC1 regulates PDL1 expression and tumor immunity through the c-Met/AKT/mTOR pathway in gastric cancer cells.
    Tong G; Cheng B; Li J; Wu X; Nong Q; He L; Li X; Li L; Wang S
    Cancer Med; 2019 Nov; 8(16):7044-7054. PubMed ID: 31557409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
    Catenacci DV; Ang A; Liao WL; Shen J; O'Day E; Loberg RD; Cecchi F; Hembrough T; Ruzzo A; Graziano F
    Cancer; 2017 May; 123(6):1061-1070. PubMed ID: 27926778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.
    Zhang J; Guo L; Liu X; Li W; Ying J
    Oncotarget; 2017 Feb; 8(6):10264-10273. PubMed ID: 28052014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive and prognostic value of PDL1 protein expression in breast cancer patients in neoadjuvant setting.
    Wu Z; Zhang L; Peng J; Xu S; Zhou L; Lin Y; Wang Y; Lu J; Yin W; Lu J
    Cancer Biol Ther; 2019; 20(6):941-947. PubMed ID: 30866717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy.
    Ha SY; Lee J; Jang J; Hong JY; Do IG; Park SH; Park JO; Choi MG; Sohn TS; Bae JM; Kim S; Kim M; Kim S; Park CK; Kang WK; Kim KM
    Int J Cancer; 2015 Apr; 136(7):1629-35. PubMed ID: 25157953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.
    Kim HS; Chon HJ; Kim H; Shin SJ; Wacheck V; Gruver AM; Kim JS; Rha SY; Chung HC
    J Surg Oncol; 2018 Jun; 117(8):1679-1686. PubMed ID: 29790169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MET in gastric cancer--discarding a 10% cutoff rule.
    Metzger ML; Behrens HM; Böger C; Haag J; Krüger S; Röcken C
    Histopathology; 2016 Jan; 68(2):241-53. PubMed ID: 26033401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas.
    Paliga A; Marginean H; Tessier-Cloutier B; Purgina B; Jonker D; Marginean EC
    Am J Clin Oncol; 2017 Dec; 40(6):543-551. PubMed ID: 26125303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.
    Nakajima M; Sawada H; Yamada Y; Watanabe A; Tatsumi M; Yamashita J; Matsuda M; Sakaguchi T; Hirao T; Nakano H
    Cancer; 1999 May; 85(9):1894-902. PubMed ID: 10223227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor MET Expression and Gene Amplification in Chinese Patients with Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer.
    Peng Z; Li Z; Gao J; Lu M; Gong J; Tang ET; Oliner KS; Hei YJ; Zhou H; Shen L
    Mol Cancer Ther; 2015 Nov; 14(11):2634-41. PubMed ID: 26330547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
    Shinmura K; Kiyose S; Nagura K; Igarashi H; Inoue Y; Nakamura S; Maeda M; Baba M; Konno H; Sugimura H
    J Surg Oncol; 2014 Mar; 109(3):189-97. PubMed ID: 24178904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IKZF3 amplification predicts worse prognosis especially in intestinal-type gastric cancer.
    Cui Z; Liang H; Luo R; Huang W; Yuan W; Zhang L; Luan L; Su J; Huang J; Xu C; Hou Y
    J Cancer Res Clin Oncol; 2024 Jul; 150(7):363. PubMed ID: 39052108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of PD1/PDL1 in gastric cancer at different microsatellite status and its correlation with infiltrating immune cells in the tumor microenvironment.
    Wang YL; Gong Y; Lv Z; Li L; Yuan Y
    J Cancer; 2021; 12(6):1698-1707. PubMed ID: 33613757
    [No Abstract]   [Full Text] [Related]  

  • 16. Expressions and clinical significances of c-MET, p-MET and E2f-1 in human gastric carcinoma.
    Wu JG; Yu JW; Wu HB; Zheng LH; Ni XC; Li XQ; Du GY; Jiang BJ
    BMC Res Notes; 2014 Jan; 7():6. PubMed ID: 24393368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and significance of CD47, PD1 and PDL1 in T-cell acute lymphoblastic lymphoma/leukemia.
    Yang K; Xu J; Liu Q; Li J; Xi Y
    Pathol Res Pract; 2019 Feb; 215(2):265-271. PubMed ID: 30466764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
    Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
    BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MET amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy.
    An X; Wang F; Shao Q; Wang FH; Wang ZQ; Wang ZQ; Chen C; Li C; Luo HY; Zhang DS; Xu RH; Li YH
    Cancer; 2014 Mar; 120(5):675-82. PubMed ID: 24804300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome.
    Lee HE; Kim MA; Lee HS; Jung EJ; Yang HK; Lee BL; Bang YJ; Kim WH
    Br J Cancer; 2012 Jul; 107(2):325-33. PubMed ID: 22644302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.